Excision Bio licenses CRISPR technology from UC Berkeley
15-11-2017
The European Patent Office (EPO) has revealed its intention to grant a patent covering the CRISPR gene-editing technology to the University of California, Berkeley, the University of Vienna, and inventor Emmanuelle Charpentier.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
C Berkeley, EPO, CRISPR, PTAB, The Broad Institute, Harvard, MIT, genome editing, CRISPR/Cas9, Federal Circuit, patent